Clinical Trial

Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This trial will administer laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis from gastric cancer (GPC) who are receiving standard of care systemic chemotherapy.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-03
notable Primary completion pushed: 2030-04-30 -> 2030-06-30 2026-07-03
minor Completion pushed: 2034-04-30 -> 2034-06-30 2026-07-03
Trial Details
NCT Number NCT07475286
Lead Sponsor Mohammad Haroon Asif Choudry
Collaborators: Dr. Samer AlMasri, MD
Conditions Synchronous Gastric Peritoneal Carcinomatosis, Gastroesophageal Peritoneal Carcinomatosis
Enrollment 22 participants
Start Date 2026-06-12
Primary Completion 2030-06-30 (estimated)
Study Completion 2034-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-02